Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 23

1.

Effect of genetic variation in the organic cation transporter 2 on the renal elimination of metformin.

Chen Y, Li S, Brown C, Cheatham S, Castro RA, Leabman MK, Urban TJ, Chen L, Yee SW, Choi JH, Huang Y, Brett CM, Burchard EG, Giacomini KM.

Pharmacogenet Genomics. 2009 Jul;19(7):497-504. doi: 10.1097/FPC.0b013e32832cc7e9.

2.

Phase II study of picoplatin as second-line therapy for patients with small-cell lung cancer.

Eckardt JR, Bentsion DL, Lipatov ON, Polyakov IS, Mackintosh FR, Karlin DA, Baker GS, Breitz HB.

J Clin Oncol. 2009 Apr 20;27(12):2046-51. doi: 10.1200/JCO.2008.19.3235. Epub 2009 Mar 16.

PMID:
19289620
3.

Functional characterization of the human organic cation transporter 2 variant p.270Ala>Ser.

Zolk O, Solbach TF, K├Ânig J, Fromm MF.

Drug Metab Dispos. 2009 Jun;37(6):1312-8. doi: 10.1124/dmd.108.023762. Epub 2009 Feb 27.

4.

New-generation platinum agents for solid tumors.

Shah N, Dizon DS.

Future Oncol. 2009 Feb;5(1):33-42. doi: 10.2217/14796694.5.1.33. Review.

PMID:
19243296
5.

Significance of organic cation transporter 3 (SLC22A3) expression for the cytotoxic effect of oxaliplatin in colorectal cancer.

Yokoo S, Masuda S, Yonezawa A, Terada T, Katsura T, Inui K.

Drug Metab Dispos. 2008 Nov;36(11):2299-306. doi: 10.1124/dmd.108.023168. Epub 2008 Aug 18.

6.

Developments in the treatment of non-small cell lung cancer.

Gkiozos I, Charpidou A, Syrigos K.

Anticancer Res. 2007 Jul-Aug;27(4C):2823-7. Review.

7.

The resurgence of platinum-based cancer chemotherapy.

Kelland L.

Nat Rev Cancer. 2007 Aug;7(8):573-84. Epub 2007 Jul 12. Review.

PMID:
17625587
8.

Differential contribution of organic cation transporters, OCT2 and MATE1, in platinum agent-induced nephrotoxicity.

Yokoo S, Yonezawa A, Masuda S, Fukatsu A, Katsura T, Inui K.

Biochem Pharmacol. 2007 Aug 1;74(3):477-87. Epub 2007 Mar 12.

PMID:
17582384
9.

Transport of paraquat by human organic cation transporters and multidrug and toxic compound extrusion family.

Chen Y, Zhang S, Sorani M, Giacomini KM.

J Pharmacol Exp Ther. 2007 Aug;322(2):695-700. Epub 2007 May 10.

10.

Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action.

Shu Y, Sheardown SA, Brown C, Owen RP, Zhang S, Castro RA, Ianculescu AG, Yue L, Lo JC, Burchard EG, Brett CM, Giacomini KM.

J Clin Invest. 2007 May;117(5):1422-31.

11.

JAMA patient page. Lung cancer.

Zeller JL, Lynm C, Glass RM.

JAMA. 2007 Mar 7;297(9):1022. No abstract available.

PMID:
17341716
12.

Chemotherapy resistance and oncogene expression in non-small cell lung cancer.

d'Amato TA, Landreneau RJ, Ricketts W, Huang W, Parker R, Mechetner E, Yu IR, Luketich JD.

J Thorac Cardiovasc Surg. 2007 Feb;133(2):352-63. Epub 2007 Jan 9.

13.

Organic cation transporters are determinants of oxaliplatin cytotoxicity.

Zhang S, Lovejoy KS, Shima JE, Lagpacan LL, Shu Y, Lapuk A, Chen Y, Komori T, Gray JW, Chen X, Lippard SJ, Giacomini KM.

Cancer Res. 2006 Sep 1;66(17):8847-57.

14.
15.

Platinum(IV) analogues of AMD473 (cis-[PtCl2(NH3)(2-picoline)]): preparative, structural, and electrochemical studies.

Battle AR, Choi R, Hibbs DE, Hambley TW.

Inorg Chem. 2006 Aug 7;45(16):6317-22.

PMID:
16878941
16.

Abrogation of fibroblast activation protein enzymatic activity attenuates tumor growth.

Cheng JD, Valianou M, Canutescu AA, Jaffe EK, Lee HO, Wang H, Lai JH, Bachovchin WW, Weiner LM.

Mol Cancer Ther. 2005 Mar;4(3):351-60.

17.

Platinums in lung cancer: sufficient or necessary?

Bunn PA Jr.

J Clin Oncol. 2005 May 1;23(13):2882-3. Epub 2005 Feb 22. No abstract available.

PMID:
15728220
18.

Role of human copper transporter Ctr1 in the transport of platinum-based antitumor agents in cisplatin-sensitive and cisplatin-resistant cells.

Song IS, Savaraj N, Siddik ZH, Liu P, Wei Y, Wu CJ, Kuo MT.

Mol Cancer Ther. 2004 Dec;3(12):1543-9. Erratum in: Mol Cancer Ther. 2005 May;4(5):864.

19.

Platinum drugs in the treatment of non-small-cell lung cancer.

Cosaert J, Quoix E.

Br J Cancer. 2002 Oct 7;87(8):825-33. Review.

20.

Uptake of the anticancer drug cisplatin mediated by the copper transporter Ctr1 in yeast and mammals.

Ishida S, Lee J, Thiele DJ, Herskowitz I.

Proc Natl Acad Sci U S A. 2002 Oct 29;99(22):14298-302. Epub 2002 Oct 7.

Supplemental Content

Support Center